Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 15, 2016 - Issue 10
Submit an article Journal homepage
1,926
Views
99
CrossRef citations to date
0
Altmetric
Review

An update of safety of clinically used atypical antipsychotics

L. OrsoliniSchool of Life and Medical Sciences, University of Hertfordshire, Hatfield, Herts, United Kingdom;Villa San Giuseppe Hospital, Hermanas Hospitalarias, Ascoli Piceno, Italy;Polyedra Research Group, Teramo, Italy;Department of Psychiatry and Neuropsychology, University of Maastricht, Maastricht, The Netherlands
,
C. TomasettiPolyedra Research Group, Teramo, Italy;NHS, Department of Mental Health ASL Teramo, Psychiatric Service of Diagnosis and Treatment, Hospital ‘Maria SS dello Splendore,’Giulianova, Italy;Laboratory of Molecular and Translational Psychiatry, Department of Neuroscience, Reproductive and Odontostomatogical Sciences, University of Naples ‘Federico II,’Napoli, Italy
,
A. ValcheraVilla San Giuseppe Hospital, Hermanas Hospitalarias, Ascoli Piceno, Italy;Polyedra Research Group, Teramo, Italy
,
R. VecchiottiVilla San Giuseppe Hospital, Hermanas Hospitalarias, Ascoli Piceno, Italy;Polyedra Research Group, Teramo, Italy;Department of Psychiatry and Neuropsychology, University of Maastricht, Maastricht, The Netherlands
,
I. MatarazzoNHS, Department of Mental Health ASL Teramo, Psychiatric Service of Diagnosis and Treatment, Hospital ‘G. Mazzini,’Teramo, Italy;Department of Neuroscience and Imaging, University ‘G. D’Annunzio,’Chieti, Italy
,
F. VellanteNHS, Department of Mental Health ASL Teramo, Psychiatric Service of Diagnosis and Treatment, Hospital ‘G. Mazzini,’Teramo, Italy;Department of Neuroscience and Imaging, University ‘G. D’Annunzio,’Chieti, Italy
,
F. IasevoliPolyedra Research Group, Teramo, Italy;Laboratory of Molecular and Translational Psychiatry, Department of Neuroscience, Reproductive and Odontostomatogical Sciences, University of Naples ‘Federico II,’Napoli, Italy
,
E. F. BuonaguroPolyedra Research Group, Teramo, Italy;Laboratory of Molecular and Translational Psychiatry, Department of Neuroscience, Reproductive and Odontostomatogical Sciences, University of Naples ‘Federico II,’Napoli, Italy
,
M. FornaroPolyedra Research Group, Teramo, Italy;New York Psychiatric Institute, Columbia University, New York, NY, USA
,
A. L. C. FiengoPolyedra Research Group, Teramo, Italy
,
G. MartinottiDepartment of Neuroscience and Imaging, University ‘G. D’Annunzio,’Chieti, Italy
,
M. MazzaPolyedra Research Group, Teramo, Italy;Department of Life, Health and Environmental Sciences, University of L’Aquila, L’Aquila, Italy
,
G. PernaDepartment of Clinical Neurosciences, Hermanas Hospitalarias, FoRiPsi, Villa San Benedetto Menni, Albese con Cassano, Como, Italy;Department of Psychiatry and Behavioral Sciences, Leonard Miller School of Medicine, University of Miami, Miami, FL, USA
,
A. CaranoNHS, Department of Mental Health ASL Ascoli Piceno, Psychiatric Service of Diagnosis and Treatment, Hospital ‘Maria SS del Soccorso,’San Benedetto del Tronto, Italy
,
A. De BartolomeisLaboratory of Molecular and Translational Psychiatry, Department of Neuroscience, Reproductive and Odontostomatogical Sciences, University of Naples ‘Federico II,’Napoli, Italy
,
M. Di GiannantonioNew York Psychiatric Institute, Columbia University, New York, NY, USA
&
D. De BerardisPolyedra Research Group, Teramo, Italy;NHS, Department of Mental Health ASL Teramo, Psychiatric Service of Diagnosis and Treatment, Hospital ‘G. Mazzini,’Teramo, Italy;Department of Neuroscience and Imaging, University ‘G. D’Annunzio,’Chieti, ItalyCorrespondence[email protected]
 show all
Pages 1329-1347 | Received 23 Jan 2016, Accepted 10 Jun 2016, Published online: 04 Jul 2016

Citations (99)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (12)

Catherine Nury, Celine Merg, Yvan Eb-Levadoux, David Bovard, Matthieu Porchet, Fabio Maranzano, Isidora Loncarevic, Shahrzad Tavalaei, Eleonore Lize, Ramona Liliana Demenescu, Hasmik Yepiskoposyan, Julia Hoeng, Nikolai V Ivanov, Kasper Renggli & Bjoern Titz. (2023) Toxicoproteomics reveals an effect of clozapine on autophagy in human liver spheroids. Toxicology Mechanisms and Methods 33:5, pages 401-410.
Read now
Kyle Pérez, Michele Berrios, Bruce Pyenson & Heidi C. Waters. (2023) Treatment patterns and clinical outcomes among Medicare beneficiaries using antipsychotic medications for FDA-approved indications before and after transitioning from the community to a nursing home. Current Medical Research and Opinion 39:4, pages 589-595.
Read now
Laura Orsolini, Francesca Sceusa, Simone Pompili, Antonella Mauro, Virginio Salvi & Umberto Volpe. (2021) Severe and persistent mental illness (SPMI) in pregnancy and breastfeeding: focus on second-generation long acting injectable antipsychotics. Expert Opinion on Drug Safety 20:10, pages 1207-1224.
Read now
Yoshiteru Takekita, Sachie Inoue, Kenji Baba & Tadashi Nosaka. (2020) Rehospitalization Risk of Receptor-Affinity Profile in Antipsychotic Drug Treatment: A Propensity Score Matching Analysis Using a Japanese Employment-Based Health Insurance Database. Neuropsychiatric Disease and Treatment 16, pages 2871-2879.
Read now
Laura Orsolini, Domenico De Berardis & Umberto Volpe. (2020) Up-to-date expert opinion on the safety of recently developed antipsychotics. Expert Opinion on Drug Safety 19:8, pages 981-998.
Read now
Jessica J Madera, Pedro Such, Cathy Zhao & Ross A Baker. (2019) Symptomatic stability with aripiprazole once-monthly: efficacy analyses from acute and long-term studies. Neuropsychiatric Disease and Treatment 15, pages 1593-1604.
Read now
Michele Fornaro, Andrea Fusco, Annalisa Anastasia, Carlo Ignazio Cattaneo & Domenico De Berardis. (2019) Brexpiprazole for treatment-resistant major depressive disorder. Expert Opinion on Pharmacotherapy 20:16, pages 1925-1933.
Read now
Xue Song, Antoine C. El Khoury, Matthew Brouillette, David Smith & Kruti Joshi. (2019) Treatment discontinuation of long-acting injectables or oral atypical antipsychotics among Medicaid recipients with schizophrenia. Journal of Medical Economics 22:11, pages 1105-1112.
Read now
Lindsay A. Bartram, Juan Lozano & Daniel L. Coury. (2019) Aripiprazole for treating irritability associated with autism spectrum disorders. Expert Opinion on Pharmacotherapy 20:12, pages 1421-1427.
Read now
Janet Sultana, Francesco Giorgianni, Federico Rea, Ersilia Lucenteforte, Niccolò Lombardi, Alessandro Mugelli, Alfredo Vannacci, Rosa Liperoti, Ursula Kirchmayer, Cristiana Vitale, Alessandro Chinellato, Giuseppe Roberto, Giovanni Corrao & Gianluca Trifirò. (2019) All-cause mortality and antipsychotic use among elderly persons with high baseline cardiovascular and cerebrovascular risk: a multi-center retrospective cohort study in Italy. Expert Opinion on Drug Metabolism & Toxicology 15:2, pages 179-188.
Read now
Sidra Mahmood, Shahzad Hussain, Taufeeq ur Rehman, Corrado Barbui, Amanj Baker Kurdi & Brian Godman. (2019) Trends in the prescribing of antipsychotic medicines in Pakistan: implications for the future. Current Medical Research and Opinion 35:1, pages 51-61.
Read now
Fernanda S Tonin, Astrid Wiens, Fernando Fernandez-Llimos & Roberto Pontarolo. (2016) Iloperidone in the treatment of schizophrenia: an evidence-based review of its place in therapy. Core Evidence 11, pages 49-61.
Read now

Articles from other publishers (87)

Christine Zhang, Lillian Carter & Carrie J McAdams. (2023) Psychopharmacological considerations for comorbid anorexia nervosa and bipolar disorder. Psychiatry Research Case Reports 2:2, pages 100192.
Crossref
Aderonke Oyetunji, Val Bellman & Jianwei Jiao. (2023) Transient eosinophilic colitis in clozapine use. Psychiatry Research Case Reports 2:2, pages 100178.
Crossref
Stefania Chiappini, Alessio Mosca, Andrea Miuli, Francesco Di Carlo, Giacomo d'Andrea, Alessandra Napolitano, Monica Santangelo, Corradina Esposito, Anna Rosazza, Elena Haefele, Gilberto Di Petta, Mauro Pettorruso, Stefano L. Sensi & Giovanni Martinotti. (2023) Aripiprazole once monthly as a maintenance treatment for patients with schizophrenia and alcohol/substance use disorder: an observational, real-world study. Advances in Dual Diagnosis 16:3, pages 185-198.
Crossref
Ricardo Corral, Enrique Bojórquez, Marcelo Cetkovich-Bakmas, Rodrigo Córdoba, Julio Chestaro, Clarissa Gama, Gerardo García Bonetto, Carlos López Jaramillo, Ricardo Alberto Moreno, Bernardo Ng, Edilberto Pena de Leon, Luis Risco, Hernán Silva & Gustavo Vazquez. (2023) Latin American consensus recommendations for the management and treatment of patients with treatment-resistant depression (TRD). Spanish Journal of Psychiatry and Mental Health.
Crossref
Jennifer Connell, Brittany McCann, Xiaoke Feng, Matthew S. Shotwell, Christopher G. Hughes & Christina S. Boncyk. (2023) The Association of Nonmodifiable Patient Factors on Antipsychotic Medication use in the Intensive Care Unit. Journal of Intensive Care Medicine.
Crossref
Yarmila Elena Valencia Carlo, Ricardo Arturo Saracco-Alvarez, Verónica Angela Valencia Carlo, Daniela Vázquez Vega, Guillermina Natera Rey & Raul Ivan Escamilla Orozco. (2023) Adverse effects of antipsychotics on sleep in patients with schizophrenia. Systematic review and meta-analysis. Frontiers in Psychiatry 14.
Crossref
Damian Koevoet, P. K. H. Deschamps & J. L. Kenemans. (2023) Catecholaminergic and cholinergic neuromodulation in autism spectrum disorder: A comparison to attention-deficit hyperactivity disorder. Frontiers in Neuroscience 16.
Crossref
Yiwen Yuan, Xiaoqing Li, Xingmei Jiang, Zhixiong Li, Ying Ou & Zhe Li. (2022) Acne caused by ziprasidone in a young patient with bipolar disorder: A case report. Frontiers in Psychiatry 13.
Crossref
Bingyang XueYasuyoshi IshiwataYohei KawanoHiromitsu TakahashiKenichi NegishiTakao AoyamaMasashi Nagata. (2022) Paliperidone-Induced Acute Hyperglycemia Is Caused by Adrenaline Secretion <i>via</i> the Activation of Hypothalamic AMP-Activated Protein Kinase. Biological and Pharmaceutical Bulletin 45:11, pages 1669-1677.
Crossref
Laura A. Bajor, Charmi Balsara & David N. Osser. (2022) An evidence-based approach to psychopharmacology for posttraumatic stress disorder (PTSD) - 2022 update. Psychiatry Research 317, pages 114840.
Crossref
Waseem Sultan, Anup Mathew, Matthew R. D. Brown, Juan F. Gálvez-Flórez & Guillermo Moreno-Sanz. (2022) Cannabis-Based Medicinal Products in the Management of Emotionally Unstable Personality Disorder (EUPD): A Narrative Review and Case Series. Brain Sciences 12:11, pages 1467.
Crossref
Giovanni Martinotti, Stefania Chiappini, Alessio Mosca, Andrea Miuli, Maria Chiara Santovito, Mauro Pettorruso, Valentin Skryabin, Stefano L. Sensi & Massimo Di Giannantonio. (2022) Atypical Antipsychotic Drugs in Dual Disorders: Current Evidence for Clinical Practice. Current Pharmaceutical Design 28:27, pages 2241-2259.
Crossref
Jana Osacka, Alexander Kiss & Zdenko Pirnik. (2022) Possible involvement of apoptosis in the antipsychotics side effects: A mini‐review. Clinical and Experimental Pharmacology and Physiology 49:8, pages 836-847.
Crossref
Giulio Sparacino, Norma Verdolini, Eduard Vieta & Isabella Pacchiarotti. (2022) Existing and emerging pharmacological approaches to the treatment of mania: A critical overview. Translational Psychiatry 12:1.
Crossref
Yizhou Jiang, Uma Gaur, Zhibai Cao, Sheng-Tao Hou & Wenhua Zheng. (2022) Dopamine D1- and D2-like receptors oppositely regulate lifespan via a dietary restriction mechanism in Caenorhabditis elegans. BMC Biology 20:1.
Crossref
Laura Orsolini, Giulia Menculini, Silvia Tempia Valenta, Michele Fiorani, David Rocchetti, Virginio Salvi, Alfonso Tortorella & Umberto Volpe. (2022) Depressive and Anxious Temperaments as Predictors of Late Onset Bipolar Disorder? Preliminary Results of a “Real World” Exploratory Study. Frontiers in Psychiatry 13.
Crossref
Yu Wang, Nousayhah Amdanee & Xiangrong Zhang. (2022) Exosomes in schizophrenia: Pathophysiological mechanisms, biomarkers, and therapeutic targets. European Psychiatry 65:1.
Crossref
Stefania Chiappini, Alessio Mosca, Giovanni Martinotti, Francesco Di Carlo, Andrea Miuli, Luigi Dattoli, Mauro Pettorruso & Massimo Di Giannantonio. (2022) Brexpiprazole as a new approach of treatment in somatization disorder. Emerging Trends in Drugs, Addictions, and Health 2, pages 100031.
Crossref
J. Helen Yoo & Eric B. London. 2022. Handbook of Autism and Pervasive Developmental Disorder. Handbook of Autism and Pervasive Developmental Disorder 1219 1235 .
Stefan Kloiber. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1559 1574 .
Johannes Gfesser & Sarah Kittel-Schneider. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1639 1686 .
Andrea Amerio, Costanza Giacomini, Laura Fusar-Poli, Andrea Aguglia, Alessandra Costanza, Gianluca Serafini, Eugenio Aguglia & Mario Amore. (2021) Efficacy and Safety of Lurasidone in Children and Adolescents: Recommendations for Clinical Management and Future Research. Current Pharmaceutical Design 27:39, pages 4062-4069.
Crossref
Hui Gao, Chao Luo, Si-Jing Tu, Ru-Ping Lu, Lin-Na Jiang, Hui-Jun Qiao, Qu Lin, Ning-Ning Li & Jian-Hua Chen. (2021) The Effect of Yijinjing on the Cognitive Function of Patients With Chronic Schizophrenia. Frontiers in Psychiatry 12.
Crossref
Yelei Zhang, Xiaoyue Li, Xianhu Yao, Yating Yang, Xiaoshuai Ning, Tongtong Zhao, Lei Xia, Yulong Zhang, Kai Zhang & Huanzhong Liu. (2021) Do Leptin Play a Role in Metabolism–Related Psychopathological Symptoms?. Frontiers in Psychiatry 12.
Crossref
Eva Češková. (2021) Cariprazine in the treatment of schizophrenia. Psychiatrie pro praxi 22:2, pages 94-98.
Crossref
Mei-Chi Hsu, Shang-Chi Lee & Wen-Chen Ouyang. (2021) Use of Charlson Comorbidity Index and Nomogram to Predict Mortality in Elderly Patients with Late-Life Schizophrenia. Healthcare 9:7, pages 783.
Crossref
Norma Verdolini, Diego Hidalgo‐Mazzei, Laura Del Matto, Michele Muscas, Isabella Pacchiarotti, Andrea Murru, Ludovic Samalin, Alberto Aedo, Mauricio Tohen, Heinz Grunze, Allan H. Young, André F. Carvalho & Eduard Vieta. (2021) Long‐term treatment of bipolar disorder type I: A systematic and critical review of clinical guidelines with derived practice algorithms. Bipolar Disorders 23:4, pages 324-340.
Crossref
Ying-Shan Chung, Shih-Chieh Shao, Mei-Hong Chi, Swu-Jane Lin, Chien-Chou Su, Yea-Huei Kao Yang, Yen-Kuang Yang & Edward Chia-Cheng Lai. (2020) Comparative cardiometabolic risk of antipsychotics in children, adolescents and young adults. European Child & Adolescent Psychiatry 30:5, pages 769-783.
Crossref
Louise Carton, Régis Bordet, François Montastruc & Romain Guilhaumou. (2021) Towards personalized pharmacology: Antipsychotics and schizophrenia. Therapies 76:2, pages 137-147.
Crossref
Ann A. Verhaegen & Luc F. Van Gaal. (2021) Drugs Affecting Body Weight, Body Fat Distribution, and Metabolic Function—Mechanisms and Possible Therapeutic or Preventive Measures: an Update. Current Obesity Reports 10:1, pages 1-13.
Crossref
Eimear O’ Neill, Deirdre Carolan, Sarah Kennedy & Sandra Barry. (2021) Late-Onset Neutropenia in Long-Term Clozapine Use and Its Management Utilizing Prophylactic G-CSF. Case Reports in Psychiatry 2021, pages 1-5.
Crossref
Ali Bani-Fatemi, Christopher Adanty, Nasia Dai, Ariel Graff, Philip Gerretsen & Vincenzo De Luca. (2021) Chromosome 22 Deletions and Suicidal Behavior in Schizophrenia. Neuropsychobiology 80:5, pages 393-400.
Crossref
Sophie R. Vaccarino & Sidney H. Kennedy. 2021. Ketamine for Treatment-Resistant Depression. Ketamine for Treatment-Resistant Depression 33 84 .
Manfred Döpfner & Veit Roessner. 2020. Psychiatrie und Psychotherapie des Kindes- und Jugendalters. Psychiatrie und Psychotherapie des Kindes- und Jugendalters 1 23 .
Stefan Kloiber. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1 17 .
Jeff A. Dennis, Lisaann S. Gittner, J. Drew Payne & Kenneth Nugent. (2020) Characteristics of U.S. adults taking prescription antipsychotic medications, National Health and Nutrition Examination Survey 2013–2018. BMC Psychiatry 20:1.
Crossref
Hiroyuki Fujiyama, Hiroko Sugawara, Teppei Kanno, Kazuhiro Kawahara, Hibiki Tanaka, Ryuji Fukuhara, Shuken Boku & Minoru Takebayashi. (2020) Combination therapy of brexpiprazole and aripiprazole for an adolescent patient with a first episode of schizophrenia: A case report. Psychiatry and Clinical Neurosciences 74:12, pages 666-667.
Crossref
Giampaolo Perna, Francesco Cuniberti, Silvia Daccò, Massimiliano Grassi & Daniela Caldirola. (2020) ‘Precision’ or ‘personalized’ psychiatry: different terms – same content?. Fortschritte der Neurologie · Psychiatrie 88:12, pages 759-766.
Crossref
Rukhsana Nawaz, Saima Gul, Rafat Amin, Tanzeel Huma & Fadwa Al Mughairbi. (2020) Overview of schizophrenia research and treatment in Pakistan. Heliyon 6:11, pages e05545.
Crossref
László-István Bába, Zsolt Gáll, Melinda Kolcsár, Zsuzsánna Pap, Zoltán V. Varga, Béla Kovács, Beatrix Hack & Imre-Zoltán Kun. (2020) Effect on Body Weight and Adipose Tissue by Cariprazine: A Head-to-Head Comparison Study to Olanzapine and Aripiprazole in Rats. Scientia Pharmaceutica 88:4, pages 50.
Crossref
Alice Sanson & Marco A. Riva. (2020) Anti-stress Properties of Atypical Antipsychotics. Pharmaceuticals 13:10, pages 322.
Crossref
Carlo Piccinni, Letizia Dondi, Giulia Ronconi, Silvia Calabria, Immacolata Esposito, Antonella Pedrini, Aldo P. Maggioni, Corrado Barbui & Nello Martini. (2020) Real-world data on new users of atypical antipsychotics: characterisation, prescription patterns, healthcare costs and early cardio-metabolic occurrences from a large Italian database. European Journal of Clinical Pharmacology 76:9, pages 1301-1310.
Crossref
Willie R. Earley, Maria V. Burgess, Barbara Khan, Ludmyla Rekeda, Trisha Suppes, Mauricio Tohen & Joseph R. Calabrese. (2019) Efficacy and safety of cariprazine in bipolar I depression: A double‐blind, placebo‐controlled phase 3 study. Bipolar Disorders 22:4, pages 372-384.
Crossref
Michael Chez, Shawn Kile, Christopher Lepage, Carol Parise, Bobbie Benabides & Andrea Hankins. (2018) A Randomized, Placebo-Controlled, Blinded, Crossover, Pilot Study of the Effects of Dextromethorphan/Quinidine for the Treatment of Neurobehavioral Symptoms in Adults with Autism. Journal of Autism and Developmental Disorders 50:5, pages 1532-1538.
Crossref
Wenqiang Li, Fuping Sun, Xiaoge Guo, Yunqing Hu, Shuang Ding, Minli Ding, Meng Song, Minglong Shao, Yongfeng Yang, Weiyun Guo, Luwen Zhang, Yan Zhang, Xiujuan Wang, Xi Su & Luxian Lv. (2020) Behavioral abnormalities and phosphorylation deficits of extracellular signal-regulated kinases 1 and 2 in rat offspring of the maternal immune activation model. Physiology & Behavior 217, pages 112805.
Crossref
Eric B. London, J. Helen Yoo, Eric D. Fethke & Barbie Zimmerman-Bier. (2020) The Safety and Effectiveness of High-Dose Propranolol as a Treatment for Challenging Behaviors in Individuals With Autism Spectrum Disorders. Journal of Clinical Psychopharmacology 40:2, pages 122-129.
Crossref
Hui Wang, Ling Xiao, Hui-Ling Wang & Gao-Hua Wang. (2020) Efficacy and safety of lurasidone versus placebo as adjunctive to mood stabilizers in bipolar I depression: A meta-analysis. Journal of Affective Disorders 264, pages 227-233.
Crossref
Charles D. Ciccone. 2020. Guccione's Geriatric Physical Therapy. Guccione's Geriatric Physical Therapy 102 136 .
Johannes Gfesser & Sarah Kittel-Schneider. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1 49 .
Chunhui Wu, Yu Wang, Feipu Yang, Wenqiang Shi, Zhen Wang, Ling He, Yang He & Jingshan Shen. (2019) Synthesis and Biological Evaluation of Five‐Atom‐Linker‐Based Arylpiperazine Derivatives with an Atypical Antipsychotic Profile. ChemMedChem 14:24, pages 2042-2051.
Crossref
Peifan Li, Yiming Wang, Xingde Liu, Zhen Zhou, Jun Wang, Haiyan Zhou, Lei Zheng & Lixia Yang. (2019) Atypical antipsychotics induce human osteoblasts apoptosis via Wnt/β-catenin signaling. BMC Pharmacology and Toxicology 20:1.
Crossref
Amulyashree Sridhar, Sharvani GS, AH Manjunatha Reddy, Biplab Bhattacharjee & Kalyan Nagaraj. (2019) The Eminence of Co-Expressed Ties in Schizophrenia Network Communities. Data 4:4, pages 149.
Crossref
Marit Tveito, Robert Løvsletten Smith, Gudrun Høiseth & Espen Molden. (2019) The Effect of Valproic Acid on Olanzapine Serum Concentration. Journal of Clinical Psychopharmacology 39:6, pages 561-566.
Crossref
Dimy Fluyau, Paroma Mitra & Kervens Lorthe. (2019) Antipsychotics for Amphetamine Psychosis. A Systematic Review. Frontiers in Psychiatry 10.
Crossref
Jie Jia, Jun Shen, Fei-Hu Liu, Hei Kiu Wong, Xin-Jing Yang, Qiang-Ju Wu, Hui Zhang, Hua-Ning Wang, Qing-Rong Tan & Zhang-Jin Zhang. (2019) Effectiveness of Electroacupuncture and Electroconvulsive Therapy as Additional Treatment in Hospitalized Patients With Schizophrenia: A Retrospective Controlled Study. Frontiers in Psychology 10.
Crossref
Min Dong, Liang-Nan Zeng, Qinge Zhang, Shu-Yu Yang, Lian-Yu Chen, Eunice Najoan, Roy Abraham Kallivayalil, Kittisak Viboonma, Ruzita Jamaluddin, Afzal Javed, Duong Thi Quynh Hoa, Hitoshi Iida, Kang Sim, Thiha Swe, Yan-Ling He, Yongchon Park, Helal Uddin Ahmed, Angelo De Alwis, Helen F.K. Chiu, Norman Sartorius, Chay-Hoon Tan, Mian-Yoon Chong, Naotaka Shinfuku, Shih-Ku Lin, Ajit Avasthi, Sandeep Grover, Chee H. Ng, Gabor S. Ungvari & Yu-Tao Xiang. (2019) Prescription of antipsychotic and concomitant medications for adult Asian schizophrenia patients: Findings of the 2016 Research on Asian Psychotropic Prescription Patterns (REAP) survey. Asian Journal of Psychiatry 45, pages 74-80.
Crossref
Jean-Michel Azorin & Nicolas Simon. (2019) Dopamine Receptor Partial Agonists for the Treatment of Bipolar Disorder. Drugs 79:15, pages 1657-1677.
Crossref
Sylwia Łukasiewicz, Antoni Mikołajczyk, Marta Szczęch, Krzysztof Szczepanowicz, Piotr Warszyński & Marta Dziedzicka-Wasylewska. (2019) Encapsulation of clozapine into polycaprolactone nanoparticles as a promising strategy of the novel nanoformulation of the active compound. Journal of Nanoparticle Research 21:7.
Crossref
Hsiao-Fen Hsu, Chia-Chan Kao, Ti Lu, Jeremy C. Ying & Sheng-Yu Lee. (2019) Differences in the Effectiveness of Long-Acting Injection and Orally Administered Antipsychotics in Reducing Rehospitalization among Patients with Schizophrenia Receiving Home Care Services. Journal of Clinical Medicine 8:6, pages 823.
Crossref
Hubertus Himmerich, Matthew Hotopf, Hitesh Shetty, Ulrike Schmidt, Janet Treasure, Richard D. Hayes, Robert Stewart & Chin-Kuo Chang. (2018) Psychiatric comorbidity as a risk factor for mortality in people with anorexia nervosa. European Archives of Psychiatry and Clinical Neuroscience 269:3, pages 351-359.
Crossref
Mazin Khalid, Oluwole Jegede, Vijay Gayam, Ying Chi Yang, Binav Shrestha, Amrendra Mandal, Osama Mukhtar, Pavani Garlapati, Mowyad Khalid & Alix Dufresne. (2019) Clozapine-Induced Cardiotoxicity Presenting as Sepsis: A Case Report and Literature Review. Case Reports in Medicine 2019, pages 1-6.
Crossref
Yong Liu, Xiao-Jin Li, Yi Liang & Yan Kang. (2019) Pharmacological Prevention of Postoperative Delirium: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Evidence-Based Complementary and Alternative Medicine 2019, pages 1-10.
Crossref
Michiel Van Bulck, Ana Sierra-Magro, Jesus Alarcon-Gil, Ana Perez-Castillo & Jose Morales-Garcia. (2019) Novel Approaches for the Treatment of Alzheimer’s and Parkinson’s Disease. International Journal of Molecular Sciences 20:3, pages 719.
Crossref
Pilar Pérez-Ros & Francisco Martínez-Arnau. (2019) Delirium Assessment in Older People in Emergency Departments. A Literature Review. Diseases 7:1, pages 14.
Crossref
Robert Eriksson, Brian V. Broberg, Pelle L. Ishøy, Nikolaj Bak, Ulrik B. Andersen, Niklas R. Jørgensen, Filip K. Knop & Bjørn H. Ebdrup. (2019) Bone Status in Obese, Non-diabetic, Antipsychotic-Treated Patients, and Effects of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide on Bone Turnover Markers and Bone Mineral Density. Frontiers in Psychiatry 9.
Crossref
Domenico De Berardis, Michele Fornaro, Annalisa Anastasia, Federica Vellante, Alessandro Valchera, Marilde Cavuto, Giampaolo Perna, Marco Di Nicola, Gianluca Serafini, Alessandro Carano, Maurizio Pompili, Laura Orsolini, Carmine Tomasetti, Gabriella Di Emidio, Giovanni Martinotti & Massimo Di Giannantonio. 2019. Treatment Resistance in Psychiatry. Treatment Resistance in Psychiatry 349 367 .
Mirela S. Bucur, Heather Sylvester & Ana Hategan. 2019. Inpatient Geriatric Psychiatry. Inpatient Geriatric Psychiatry 3 25 .
Young Sup Woo, Won-Myong Bahk, Jung Goo Lee, Jong-Hyun Jeong, Moon-Doo Kim, InKi Sohn, Se-Hoon Shim, Duk-In Jon, Jeong Seok Seo, Kyung Joon Min, Won Kim, Hoo-Rim Song & Bo-Hyun Yoon. (2018) Korean Medication Algorithm Project for Bipolar Disorder 2018 (KMAP-BP 2018): Fourth Revision. Clinical Psychopharmacology and Neuroscience 16:4, pages 434-448.
Crossref
Esther S. LeeCarol VidalRobert L. Findling. (2018) A Focused Review on the Treatment of Pediatric Patients with Atypical Antipsychotics. Journal of Child and Adolescent Psychopharmacology 28:9, pages 582-605.
Crossref
Samantha A. Hollingworth, Karl Winckel, Nargess Saiepour, Amanda J. Wheeler, Nicholas Myles & Dan Siskind. (2018) Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993–2014. Psychopharmacology 235:7, pages 1915-1921.
Crossref
Domenico De Berardis, Gabriella Rapini, Luigi Olivieri, Domenico Di Nicola, Carmine Tomasetti, Alessandro Valchera, Michele Fornaro, Fabio Di Fabio, Giampaolo Perna, Marco Di Nicola, Gianluca Serafini, Alessandro Carano, Maurizio Pompili, Federica Vellante, Laura Orsolini, Giovanni Martinotti & Massimo Di Giannantonio. (2018) Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine. Therapeutic Advances in Drug Safety 9:5, pages 237-256.
Crossref
Antonio Bruno, Gianluca Pandolfo, Manuela Crucitti, Giulia Maria Troili, Edoardo Spina, Rocco Antonio Zoccali & Maria Rosaria Anna Muscatello. (2018) Red Yeast Rice (RYR) supplementation in patients treated with second-generation antipsychotics. Complementary Therapies in Medicine 37, pages 167-171.
Crossref
Lakshmi N Yatham, Sidney H Kennedy, Sagar V Parikh, Ayal Schaffer, David J Bond, Benicio N Frey, Verinder Sharma, Benjamin I Goldstein, Soham Rej, Serge Beaulieu, Martin Alda, Glenda MacQueen, Roumen V Milev, Arun Ravindran, Claire O'Donovan, Diane McIntosh, Raymond W Lam, Gustavo Vazquez, Flavio Kapczinski, Roger S McIntyre, Jan Kozicky, Shigenobu Kanba, Beny Lafer, Trisha Suppes, Joseph R Calabrese, Eduard Vieta, Gin Malhi, Robert M Post & Michael Berk. (2018) Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disorders 20:2, pages 97-170.
Crossref
Jing Huang, Yiming Yu, Wei Lin, Dandan Zhang, Zaichun Deng & Qunli Ding. (2018) Olanzapine-induced peripheral eosinophilia and eosinophilic pleural effusion. Medicine 97:7, pages e9996.
Crossref
Ping Ping Qian, Shuai Wang, Kai Rui Feng & Yu Jie Ren. (2018) Molecular modeling studies of 1,2,4-triazine derivatives as novel h-DAAO inhibitors by 3D-QSAR, docking and dynamics simulations. RSC Advances 8:26, pages 14311-14327.
Crossref
Laura Orsolini, Federica Vellante, Alessandro Valchera, Michele Fornaro, Alessandro Carano, Maurizio Pompili, Giampaolo Perna, Gianluca Serafini, Marco Di Nicola, Giovanni Martinotti, Massimo Di Giannantonio & Domenico De Berardis. 2018. Understanding Depression. Understanding Depression 257 268 .
Joshua D. Rosenblat & Roger S. McIntyre. (2017) Pharmacological Approaches to Minimizing Cardiometabolic Side Effects of Mood Stabilizing Medications. Current Treatment Options in Psychiatry 4:4, pages 319-332.
Crossref
Laura Orsolini, Gabriele Duccio Papanti, Domenico De Berardis, Amira Guirguis, John Martin Corkery & Fabrizio Schifano. (2017) The “Endless Trip” among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review. Frontiers in Psychiatry 8.
Crossref
A. A. Verhaegen & L. F. Van Gaal. (2017) Drug-induced obesity and its metabolic consequences: a review with a focus on mechanisms and possible therapeutic options. Journal of Endocrinological Investigation 40:11, pages 1165-1174.
Crossref
Sang Jeon & Yong-Ku Kim. (2017) Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome. International Journal of Molecular Sciences 18:10, pages 2174.
Crossref
Mei Lee, Dorian Marshall & Sahoo Saddichha. (2017) Lurasidone-Associated Neuroleptic Malignant Syndrome. Journal of Clinical Psychopharmacology 37:5, pages 639-640.
Crossref
Chien-Chih Chen, Li-Wen Hsu, Kuang-Tzu Huang, Shigeru Goto, Chao-Long Chen & Toshiaki Nakano. (2017) Overexpression of Insig-2 inhibits atypical antipsychotic-induced adipogenic differentiation and lipid biosynthesis in adipose-derived stem cells. Scientific Reports 7:1.
Crossref
Hainimu Xiamuxi, Zhen Wang, Jianfeng Li, Yu Wang, Chunhui Wu, Feipu Yang, Xiangrui Jiang, Yongjian Liu, Qingjie Zhao, Weiming Chen, Jian Zhang, Yuanchao Xie, Tianwen Hu, Mingshuo Xu, Shuang Guo, Haji Akber Aisa, Yang He & Jingshan Shen. (2017) Synthesis and biological investigation of tetrahydropyridopyrimidinone derivatives as potential multireceptor atypical antipsychotics. Bioorganic & Medicinal Chemistry 25:17, pages 4904-4916.
Crossref
Qing Li, Dong Guo, Hong Yang, Zhi Ye, Jin Huang & Yan Shu. (2017) Metabolic Response to Olanzapine in Healthy Chinese Subjects with rs7093146 Polymorphism in Transcription Factor 7-like 2 Gene ( TCF7L2 ): A Prospective Study . Basic & Clinical Pharmacology & Toxicology 120:6, pages 601-609.
Crossref
Cristian Palmiere, Marc Augsburger & Vincent Varlet. (2017) Disturbances of glucose metabolism associated with the use of psychotropic drugs: A post-mortem evaluation. Forensic Science International 274, pages 33-37.
Crossref
Michele Fornaro, Domenico De Berardis, Giampaolo Perna, Marco Solmi, Nicola Veronese, Laura Orsolini, Elisabetta Filomena Buonaguro, Felice Iasevoli, Cristiano André Köhler, André Ferrer Carvalho & Andrea de Bartolomeis. (2017) Lurasidone in the Treatment of Bipolar Depression: Systematic Review of Systematic Reviews. BioMed Research International 2017, pages 1-17.
Crossref
Katherine Amodeo, Ruth Schneider & Irene Hegeman Richard. (2016) Call to Caution with the Use of Atypical Antipsychotics for Treatment of Depression in Older Adults. Geriatrics 1:4, pages 33.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.